Journal of mHealth 01/07/2019

Smart Wearable Harnesses the Power of Neurostimulation

NeuroMetrix has unveiled its smartest, smallest and most powerful wearable therapeutic to date. With new features seen for the first time at CES, the recently launched Quell® 2.0 is 50% smaller, yet 20% more powerful than its predecessor. The Company will introduce new functions at CES that include updates to the Quell app like coaching that helps users achieve the best possible outcomes. It also takes Pain Tech to a new level with an “Intensive Therapy” option and is the first wearable technology to utilise machine learning to deliver unprecedented personalization for the treatment of chronic pain.

CES Innovation Award Honoree

Named a CES® 2019 Innovation Awards Honoree, in the Fitness, Sports and Biotech product category, Quell is a 100% drug-free system that uses prescription strength nerve-stimulation technology to block chronic pain. Aspiring to be part of the solution to the chronic pain crisis, Quell is designed for multiple types and sources of pain and has been shown in clinical studies to relieve chronic pain.

How It Works

A Class II medical device, Quell® 2.0 is an advanced form of transcutaneous electrical nerve stimulation (TENS). The device is worn on the leg, regardless of the site of pain, and sends neural pulses to the brain that trigger a natural pain relief response in the central nervous system.

Worn in a breathable soft, flexible band, the Quell device has a credit card sized footprint so that it is discreet and comfortable under clothing. Quell 2.0 is powered by a proprietary neurostimulation microchip. It is 50% smaller than the original Quell device, yet it outputs up to 20% more electrical power.


Any Questions?

We're here for you.

Get in touch with us
or call 800.204.6577

Try Quell for yourself

It's risk free with our 60 day money back guarantee